Interestingly, in the study of esophageal adenocarcinoma, IGF2BP2 was found to be more highly expressed in metastatic lesions than in primary tumors (Barghash et al., 2016). The gene discussed is IGF2BP2; the disease is esophageal adenocarcinoma.